Literature DB >> 24287731

Gene expression in superior temporal cortex of schizophrenia patients.

C Sellmann1, L Villarín Pildaín, A Schmitt, F Leonardi-Essmann, P F Durrenberger, R Spanagel, T Arzberger, H Kretzschmar, M Zink, O Gruber, M Herrera-Marschitz, R Reynolds, P Falkai, P J Gebicke-Haerter, F Matthäus.   

Abstract

We investigated gene expression pattern obtained from microarray data of 10 schizophrenia patients and 10 control subjects. Brain tissue samples were obtained postmortem; thus, the different ages of the patients at death also allowed a study of the dynamic behavior of the expression patterns over a time frame of many years. We used statistical tests and dimensionality reduction methods to characterize the subset of genes differentially expressed in the two groups. A set of 10 genes were significantly downregulated, and a larger set of 40 genes were upregulated in the schizophrenia patients. Interestingly, the set of upregulated genes includes a large number of genes associated with gene transcription (zinc finger proteins and histone methylation) and apoptosis. We furthermore identified genes with a significant trend correlating with age in the control (MLL3) or the schizophrenia group (SOX5, CTRL). Assessments of correlations of other genes with the disorder (RRM1) or with the duration of medication could not be resolved, because all patients were medicated. This hypothesis-free approach uncovered a series of genes differentially expressed in schizophrenia that belong to a number of distinct cell functions, such as apoptosis, transcriptional regulation, cell motility, energy metabolism and hypoxia.

Entities:  

Mesh:

Year:  2013        PMID: 24287731     DOI: 10.1007/s00406-013-0473-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  74 in total

1.  Analysis of microarray data using Z score transformation.

Authors:  Chris Cheadle; Marquis P Vawter; William J Freed; Kevin G Becker
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

2.  Histone methylation regulates memory formation.

Authors:  Swati Gupta; Se Y Kim; Sonja Artis; David L Molfese; Armin Schumacher; J David Sweatt; Richard E Paylor; Farah D Lubin
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

Review 3.  Obstetric complications and congenital malformation in schizophrenia.

Authors:  T F McNeil; E Cantor-Graae; B Ismail
Journal:  Brain Res Brain Res Rev       Date:  2000-03

4.  Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation.

Authors:  Christopher Wynder; Mohamed-Ali Hakimi; Jonathan A Epstein; Ali Shilatifard; Ramin Shiekhattar
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

5.  GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.

Authors:  N Saeki; D H Kim; T Usui; K Aoyagi; T Tatsuta; K Aoki; K Yanagihara; M Tamura; H Mizushima; H Sakamoto; K Ogawa; M Ohki; T Shiroishi; T Yoshida; H Sasaki
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

6.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia.

Authors:  Christopher Aston; Lixin Jiang; Boris P Sokolov
Journal:  J Neurosci Res       Date:  2004-09-15       Impact factor: 4.164

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha.

Authors:  Bernhard Gess; Karl-Heinz Hofbauer; Roland H Wenger; Christiane Lohaus; Helmut E Meyer; Armin Kurtz
Journal:  Eur J Biochem       Date:  2003-05

9.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

Authors:  D R Weinberger; K F Berman; B P Illowsky
Journal:  Arch Gen Psychiatry       Date:  1988-07

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  6 in total

Review 1.  [Neurobiology of schizophrenia: new findings from the structure to the molecules].

Authors:  A Schmitt; B Malchow; D Keeser; P Falkai; A Hasan
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

2.  The neuropathology of schizophrenia: new insights from postmortem studies.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06       Impact factor: 5.270

Review 3.  Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.

Authors:  Mingyan Lin; Herbert M Lachman; Deyou Zheng
Journal:  Mol Cell Neurosci       Date:  2015-11-26       Impact factor: 4.314

4.  What genes are differentially expressed in individuals with schizophrenia? A systematic review.

Authors:  Alison K Merikangas; Matthew Shelly; Alexys Knighton; Nicholas Kotler; Nicole Tanenbaum; Laura Almasy
Journal:  Mol Psychiatry       Date:  2022-01-28       Impact factor: 13.437

5.  Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsun-Hui Tsao; Sheng-An Lee
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

6.  Identification of three genetic variants as novel susceptibility loci for body mass index in a Japanese population.

Authors:  Yoshiki Yasukochi; Jun Sakuma; Ichiro Takeuchi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Yoshiji Yamada
Journal:  Physiol Genomics       Date:  2018-01-12       Impact factor: 3.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.